Gene · 10482
Papers2,989
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
481 to 500 of 2,989
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Preliminary outcomes of raltitrexed eluting bead-transarterial chemoembolization using Callispheres® beads for gastrointestinal adenocarcinoma liver metastasis. | World J Surg Oncol | 2022 | 35821043 | PubTator, text mining | PubMed |
| Role of m6A modification in female infertility and reproductive system diseases. | Int J Biol Sci | 2022 | 35813486 | PubTator, text mining | PubMed |
| Regulatory Non-Coding RNAs in Familial Hypercholesterolemia, Theranostic Applications. | Front Cell Dev Biol | 2022 | 35813199 | PubTator, text mining | PubMed |
| Blunt aortic injury-traumatic aortic isthmus pseudoaneurysm with right iliac artery dissection aneurysm: A case report. | World J Clin Cases | 2022 | 35801016 | PubTator, text mining | PubMed |
| Downregulation of PTCD1 in Bladder Urothelial Carcinoma Predicts Poor Prognosis and Levels of Immune Infiltration. | J Oncol | 2022 | 35799606 | PubTator, text mining | PubMed |
| Context-specific regulation and function of mRNA alternative polyadenylation. | Nat Rev Mol Cell Biol | 2022 | 35798852 | PubTator, text mining | PubMed |
| The Trypanosoma brucei RNA-binding protein DRBD18 ensures correct mRNA trans splicing and polyadenylation patterns. | RNA | 2022 | 35793904 | PubTator, text mining | PubMed |
| Tislelizumab versus chemotherapy as second-line treatment of advanced or metastatic esophageal squamous cell carcinoma (RATIONALE 302): impact on health-related quality of life. | ESMO Open | 2022 | 35785595 | PubTator, text mining | PubMed |
| The Role of m6A RNA Methylation in Cancer: Implication for Nature Products Anti-Cancer Research. | Front Pharmacol | 2022 | 35784761 | PubTator, text mining | PubMed |
| Autonomous modeling of repetitive movement for rehabilitation exercise monitoring. | BMC Med Inform Decis Mak | 2022 | 35780122 | PubTator, text mining | PubMed |
| ALYREF, a novel factor involved in breast carcinogenesis, acts through transcriptional and post-transcriptional mechanisms selectively regulating the short NEAT1 isoform. | Cell Mol Life Sci | 2022 | 35776213 | PubTator, text mining | PubMed |
| Reversal of viral and epigenetic HLA class I repression in Merkel cell carcinoma. | J Clin Invest | 2022 | 35775490 | PubTator, text mining | PubMed |
| Quantification of Tumor Abnormal Proteins in the Diagnosis and Postoperative Prognostic Evaluation of Gastric Cancer. | Clin Med Insights Oncol | 2022 | 35774594 | PubTator, text mining | PubMed |
| HibeRNAtion: HIV-1 RNA Metabolism and Viral Latency. | Front Cell Infect Microbiol | 2022 | 35774399 | PubTator, text mining | PubMed |
| Altered alpha and theta oscillations correlate with sequential working memory in Parkinson's disease. | Brain Commun | 2022 | 35755636 | PubTator, text mining | PubMed |
| RAE1 is a prognostic biomarker and is correlated with clinicopathological characteristics of patients with hepatocellular carcinoma. | BMC Bioinformatics | 2022 | 35751040 | PubTator, text mining | PubMed |
| Characterization of SARS-CoV-2 Evasion: Interferon Pathway and Therapeutic Options. | Viruses | 2022 | 35746718 | PubTator, text mining | PubMed |
| Unraveling the Biology of Epithelioid Hemangioendothelioma, a TAZ-CAMTA1 Fusion Driven Sarcoma. | Cancers (Basel) | 2022 | 35740643 | PubTator, text mining | PubMed |
| Predictive and Prognostic Value of Non-Coding RNA in Breast Cancer. | Cancers (Basel) | 2022 | 35740618 | PubTator, text mining | PubMed |
| Role of RNA Biogenesis Factors in the Processing and Transport of Human Telomerase RNA. | Biomedicines | 2022 | 35740297 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10482/papers?page=25